Monitor the Q3 2026 earnings release on November 12 for revenue and EPS against consensus ($9.3M revenue, $-0.14 EPS). The CEO's commentary on the CDMO transformation and revenue growth potential will be key for assessing the company's strategic pivot.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $1.66entry
- T+1 · 7d ago −5.42%α −4.94% · $1.57
- T+5 · due 12h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BioHarvest Sciences filed a Form 6-K announcing that it will report Q3 2026 financial results on November 12, 2026, before market open. The filing contains no financial data, guidance, or material operational updates, it is purely a results-date notice.
Key Facts
- Q3 2026 results will be released before market open on November 12, 2026
- Conference call and webcast scheduled for 8:00 AM Eastern Time on November 12, 2026
- CEO Zaki Rakib will discuss strategic transformation to a CDMO-focused company
- No financial results, guidance, or material business updates are included in this filing
Financial Impact
No financial data reported; this is a results-date announcement only.
Risk Factors
- No financial data in this filing; all material information will come with the November 12 release
- Company is pre-revenue or early-stage with negative EPS history; cash runway and path to profitability are key risks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001723464-26-000062 |
| Document: bhsc_ex991.htm | 0001723464-26-000062 |
| Document: 0001723464-26-000062-index-headers.html | 0001723464-26-000062 |
| Document: 0001723464-26-000062-index.html | 0001723464-26-000062 |
| Document: 0001723464-26-000062.txt | 0001723464-26-000062 |
| Earnings Context (Synthetic; results releases only) | 0001723464-26-000062 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 7d ago | 6-K | $1.66 | awaiting T+5 | awaiting T+5 | $1.49 (−10.24%) |
Oct 13, 2026 23d ago | 6-K | $1.75 $1.67 | ▼ −4.18% | ▼ −4.64% | $1.49 (−14.61%) |
Oct 8, 2026 28d ago | 6-K | $1.50 $1.70 | ▲ +13.71% | ▲ +13.99% | $1.49 (−0.33%) |
Sep 15, 2026 7w ago | 6-K | $1.66 $1.46 | ▼ −12.05% | ▼ −14.61% | $1.49 (−10.24%) |
Sep 14, 2026 7w ago | 6-K | $1.78 $1.51 | ▼ −14.93% | ▼ −17.04% | $1.49 (−16.06%) |
Jul 15, 2026 16w ago | 6-K | $2.85 $2.18 | ▼ −23.51% | ▼ −22.53% | $1.49 (−47.72%) |
Jun 18, 2026 20w ago | 6-K | $3.26 $2.75 | ▼ −15.64% | ▼ −13.98% | $1.49 (−54.29%) |
May 28, 2026 23w ago | 6-K | $3.90 $3.56 | ▼ −8.72% | ▼ −8.67% | $1.49 (−61.79%) |
May 14, 2026 25w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.49 (−64.18%) |
May 14, 2026 25w ago | 6-K | $4.16 $3.82 | ▲ +8.17% | ▲ +7.46% | $1.49 (+64.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers